| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 982.90K | 73.50K | 20.10K | 33.85K | 30.88K | 230.45K |
| Gross Profit | -453.90K | -452.70K | -1.06M | -1.97M | -1.49M | -1.06M |
| EBITDA | -5.62M | -5.38M | -4.00M | -7.30M | -6.81M | -2.68M |
| Net Income | -5.90M | -5.90M | -4.81M | -7.30M | -7.13M | -3.53M |
Balance Sheet | ||||||
| Total Assets | 19.45M | 19.45M | 22.83M | 26.91M | 33.93M | 16.53M |
| Cash, Cash Equivalents and Short-Term Investments | 7.98M | 7.98M | 11.95M | 15.87M | 23.45M | 9.82M |
| Total Debt | 470.70K | 470.70K | 625.30K | 618.48K | 847.60K | 827.72K |
| Total Liabilities | 2.27M | 2.27M | 2.47M | 2.14M | 2.50M | 2.34M |
| Stockholders Equity | 17.18M | 17.18M | 20.36M | 24.77M | 31.44M | 14.19M |
Cash Flow | ||||||
| Free Cash Flow | -5.09M | -6.28M | -4.13M | -7.45M | -10.08M | -4.95M |
| Operating Cash Flow | -4.02M | -4.18M | -2.46M | -6.05M | -5.64M | -2.13M |
| Investing Cash Flow | 2.07M | 2.47M | -5.06M | -1.40M | -4.44M | -2.83M |
| Financing Cash Flow | 1.93M | 1.93M | -316.70K | -75.78K | 23.71M | -32.94K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £747.34M | -21.06 | -23.26% | ― | 12.58% | 12.39% | |
56 Neutral | £104.83M | ― | 15.77% | ― | -3.32% | 10.13% | |
45 Neutral | £5.62M | -25.30 | -1.39% | ― | -10.88% | -122.05% | |
43 Neutral | £76.85M | -12.04 | -31.45% | ― | 265.67% | -16.50% | |
41 Neutral | £98.44M | -3.80 | -86.37% | ― | 732.03% | 12.60% |
Ilika plc has announced the completion of its Goliath automated pilot line, marking a significant milestone in its solid-state battery production capabilities. This development enables the company to deliver 10Ah and 50Ah battery prototypes to customers, supporting internal and commercial testing programs. The pilot line’s operational status enhances manufacturing yield and consistency, positioning Ilika to meet the demands of its stakeholders and advance its commercialization and licensing objectives. Collaborations with UK Battery Industrialisation Centre and other partners will further scale up production, particularly for automotive applications.
The most recent analyst rating on (GB:IKA) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Ilika plc has announced the successful commissioning of its Goliath automated pilot line, marking a significant step in its solid-state battery production capabilities. This development allows Ilika to deliver solid-state battery prototypes to customers, enhancing manufacturing yield and consistency. The pilot line’s operational status supports the delivery of 10Ah and 50Ah battery prototypes for customer testing and validation, aligning with Ilika’s commercialisation strategy. The company plans to further scale production in collaboration with the UK Battery Industrialisation Centre and other partners, reinforcing its position in the battery technology industry and advancing towards its licensing objectives.
The most recent analyst rating on (GB:IKA) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Ilika plc has announced the issuance of 30,000 new ordinary shares following the exercise of options under its share option schemes. These shares are expected to be admitted for trading on AIM by October 6, 2025. This move will increase the company’s total issued share capital to 180,832,175 ordinary shares, which will be used by shareholders for calculating their interest in the company. This development reflects Ilika’s ongoing efforts to enhance its financial structure and market presence.
The most recent analyst rating on (GB:IKA) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Ilika plc announced the successful passing of all resolutions at its recent Annual General Meeting, reflecting strong shareholder support. The company also granted share options to its executive directors as part of its deferred Bonus Scheme, indicating a strategic move to align management interests with company performance.
The most recent analyst rating on (GB:IKA) stock is a Sell with a £33.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Ilika plc has announced the commencement of its PRIMED solid-state battery programme, supported by key partners including Jaguar Land Rover and Oxford University. The programme aims to advance the commercialisation of Ilika’s solid-state battery technology by leveraging the UK Battery Industrialisation Centre’s facilities to scale up production. This initiative builds on previous successful projects and is expected to deliver critical outcomes such as prototype cells and a production scale model, positioning Ilika to accelerate the industrialisation of its Goliath technology for the electric vehicle market.
The most recent analyst rating on (GB:IKA) stock is a Sell with a £33.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Ilika plc has announced the date for its Annual General Meeting (AGM) and the posting of its Annual Report for the year ended 30 April 2025. The AGM is scheduled for 23 September 2025, and shareholders are encouraged to vote online or appoint a proxy. The company will not conduct a business operations presentation or Q&A session at the AGM but will host a separate investor presentation through the Investor Meet Company platform. This announcement highlights Ilika’s ongoing commitment to engaging with its stakeholders and providing transparency about its operations and strategic direction.
The most recent analyst rating on (GB:IKA) stock is a Hold with a £34.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Ilika plc, in partnership with Cirtec Medical, has achieved a significant milestone in the production of its Stereax micro-batteries, completing the manufacturing process qualification at Cirtec’s US facility. This advancement marks the beginning of production for product testing and initial customer deliveries, enhancing miniaturization capabilities for implantable medical devices. The collaboration combines Ilika’s advanced battery technology with Cirtec’s manufacturing expertise, positioning both companies to meet the growing demand for miniaturized medical implants.